Compare NeoGenomics Inc. Common Stock (NEO) vs NIO Inc. (NIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs NIO Inc. — how do they compare? NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B), while NIO Inc. trades at $3.4 (market cap $8.76B). The key difference: NIO Inc. is far larger — about 4× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and NIO Inc. for 81 Days on average.
| NEO | NIO | |
|---|---|---|
Market Cap | $2.17B | $8.76B |
Volume | 1,615,943 | 36,159,487 |
Sector | Health | Consumer Cyclical |
52-Week High | $19.91 | $7.42 |
52-Week Low | $7.19 | $3.37 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $2.47B | $6.65B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NIO trades at $3.56, up 2.59% today but remains near 52-week lows amid a bearish technical outlook. The Chinese EV maker shows improving fundamentals with revenue growth to $87.49B in 2025 and narrowing losses, though profitability remains elusive. Recent strategic moves include a battery-swap partnership with Geely valued at $2.38B, potentially expanding NIO's network reach and utilization.
While analyst consensus leans bullish with a $6.23 price target, significant risks persist including intense price competition in China's EV market, negative cash flows, and high debt levels. The stock offers speculative upside if execution improves, but requires monitoring of quarterly earnings and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →
